The pharmacological inhibition of LC3-associated phagocytosis in monocytes has demonstrated that the FcγRIIA-mediated activation of the anti-inflammatory pathway is caused by LC3-associated phagocytosis in cirrhosis patients [19]. Here, MAP1LC3A is linked to Cirrhosis.